Extended-release tablets containing ranolazine for managing chronic stable angina. Utilized in cardiology departments of hospitals and outpatient clinics. Pharmaceutical manufacturers supply to wholesalers and pharmacies serving cardiologists and internal medicine specialists for patient therapy regimens.